Download the pdf version of this press release
Kristen Conte
eMeta Corporation
800.804.0103 ext. 142
Ovid Technologies Launches eMeta Software
eMeta's eRights Suite Creates New Revenue Streams by Employing Pay-Per-View Capabilities
LONDON - Dec. 2, 2003 -- eMeta Corporation, the leading provider of software that maximizes the value of digital assets and services, today announced that Ovid Technologies, a medical information solutions provider, has implemented eMeta's eRights(TM) Suite into the Ovid platform to support its PayPerView service. Using eRights, Ovid is now able to provide its customers and non-Ovid customers that link to Ovid with pay- per-view access to its renowned Journals@Ovid database. This option allows researchers, clinicians, and students to purchase full-text articles when their institution has not purchased the rights to access those journals.
Providing the critical infrastructure and applications necessary to secure and sell online research, eMeta's award-winning eRights Suite was integrated with the Ovid Web Gateway. Ovid Web Gateway is Ovid's flagship solution and provides users with a feature-rich, web-interface to access databases, full- text journals and electronic books for a seamless, efficient search and retrieval experience. eRights enforces Ovid's PayPerView policies, provides a shopping cart, customer care and customer self-care, allowing users to see their billing transactions and order history and maintain up-to-date personal information. The system manages transactions and refunds and provides report data to Ovid.
"Ovid is committed to providing information professionals with the highest quality content, tools and services that best enables them to perform their critical job functions," said Bette Brunelle, executive vice president, products and services, Ovid. "By integrating eMeta's solution into our existing web-based platform, we have taken a significant step forward in our ongoing effort to provide users with access to full text."
Journals@Ovid offers a selection of more than 1,000 high-quality medical and scientific journals from more than 50 of the top publishers worldwide. Additionally, Journals@Ovid is well-known for its robust searching, linking and integration with bibliographic databases.
"eMeta's mission is to provide our customers with the tools to offer their users greater and better subscriber options, such as the ability to purchase individual articles on an as-needed basis," said Jonathan Lewin, CEO of eMeta Corporation. "The eRights Suite creates a win-win situation for Ovid and the researchers who depend on Ovid for premium scientific and medical content."
About Ovid Technologies
Ovid (www.ovid.com) is a medical information solutions provider focused on offering the combination of content, tools and services that makes research smarter, faster and more effective. Ovid energizes the thinking of researchers and clinicians by developing the individualized experience each customer needs. We support Ovid Online and SilverPlatter Online customers, and provide a local solution for customers requiring offline access.
Ovid is used by the world's leading colleges and universities; medical schools; academic research libraries and library consortia; hospitals and healthcare systems; pharmaceutical, engineering and biotechnology companies; HMOs and clinical practices. Ovid is an operating company of Wolters Kluwer Health (WKHealth), a division of Wolters Kluwer NV, a leading worldwide publishing and information services company with 17,000 employees and operations in 26 countries.
About eMeta Corporation
eMeta is the leading provider of access control and commerce software for media and software companies. eMeta’s advanced solutions and services enable its many globally recognized customers to sell and control their digital goods and services, maximizing the value of their digital assets. Recognized by Deloitte in 2004 as one of the fastest growing technology companies in North America, eMeta counts Pearson, The McGraw-Hill Companies, IEEE, New York Times Digital, Wolters Kluwer, Celera Genomics, and iVillage among its many clients. The company is based in New York City. Additional information is available at www.emeta.com.
